Additionally, by blocking ACE, fasidotril decreases the production of Ang II, mitigating its vasoconstrictive and pro-inflammatory actions, and offering therapeutic benefits for hypertension and myocardial infarction (Tsutsui et al., 2021). The gene discussed is ACE; the disease is hypertensive disorder.